Transplant glomerulopathy
Information
- Disease name
- Transplant glomerulopathy
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03380962 | Active, not recruiting | Phase 1/Phase 2 | Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant | February 27, 2018 | July 30, 2025 |
| NCT03380377 | Completed | Phase 1/Phase 2 | Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant | February 21, 2018 | April 16, 2024 |
| NCT02057523 | Terminated | Phase 4 | Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients | September 2014 | September 2015 |
| NCT02546492 | Terminated | Phase 4 | Treatment of Chronic Antibody-mediated Rejection in Kidney Transplant With Acthar | August 2016 | May 27, 2021 |